Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): A randomised, multicentre, non-blinded, phase 3 trial

Citation

Duchesne, G, Woo, H, Bassett, J et al 2016, 'Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): A randomised, multicentre, non-blinded, phase 3 trial', Lancet Oncology, The, vol. 17, no. 6, pp. 727-737.

Year

2016

Fields of Research

  • Environmental And Occupational Health And Safety
  • Environmental And Occupational Health And Safety
  • Epidemiology
  • Epidemiology
  • Social And Cultural Anthropology
  • Social And Cultural Anthropology

Updated:  16 June 2019 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers